Related Experiment Video
Updated: Jun 9, 2026

Application and Methodology of the Non-destructive 19F Time-domain NMR Technique to Measure the Content in Fluorine-containing Drug Products
Published on: August 22, 2017
Lead-time bias in studies of cinacalcet prescriptions
Marie Evans1, Carl Michael Fored
1Division of Renal Medicine, Department of Clinical Science Intervention and Technology, Karolinska University Hospital, Huddinge, Stockholm, Sweden. Marie.Evans@ki.se
Insights
Higher serum phosphate, calcium, and parathyroid hormone levels are linked to cardiovascular death. Cinacalcet may improve mortality in hemodialysis patients, but observational study biases require cautious interpretation.
Area of Science:
- Nephrology
- Cardiology
- Clinical Pharmacology
Background:
- Elevated serum phosphate, calcium, and parathyroid hormone are associated with cardiovascular mortality.
- Secondary hyperparathyroidism is common in hemodialysis patients.
- Cinacalcet is a calcimimetic agent used to treat secondary hyperparathyroidism.
Purpose of the Study:
- To discuss the potential biases in observational studies examining the effect of cinacalcet on mortality.
- To highlight the need for cautious interpretation of findings from observational research.
Main Methods:
- Review of observational studies on cinacalcet and mortality.
- Discussion of potential confounding factors and biases in observational data.
- Analysis of the association between cinacalcet, mineral metabolism, and cardiovascular outcomes.
Main Results:
- Observational data suggest cinacalcet treatment is associated with improved all-cause and cardiovascular mortality in hemodialysis patients.
- Potential biases, such as confounding by indication and unmeasured confounders, may influence these findings.
- The observed mortality benefits require careful consideration due to the limitations of observational study designs.
Conclusions:
- While cinacalcet shows promise in reducing mortality in hemodialysis patients with secondary hyperparathyroidism, observational data must be interpreted with caution.
- Further investigation using robust study designs is needed to confirm these findings.
- Understanding and mitigating bias are crucial for accurate assessment of therapeutic interventions.
Abstract:
Observational studies have suggested a link between higher serum phosphate, calcium, parathyroid hormone levels, and cardiovascular mortality. The administration of cinacalcet has proven efficient in the treatment of secondary hyperparathyroidism among hemodialysis patients. In an observational study by Block et al., cinacalcet treatment is associated with a much improved all-cause and cardiovascular mortality. However, the results should be interpreted cautiously, as observational studies may be influenced by bias. This Commentary discusses the role of some common potential biases.
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time Course of Drug Effect
Blind Procedures
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...